Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer

In the Wake of Pandemic-Era Care Disruptions, New Challenges Arise

… COVID-19 challenges and encourage attendees to support research on the disease's implications on risk of lung cancer. …

Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

… to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center …

Inflammation’s Dark Symphony: Lung Cancer and Depression in Concert

… Dr. Barbara Andersen’s research has shown depression severity is associated with …

Gender Disparity in Lung Cancer

… for gender-sensitive approaches in healthcare policy, research, and clinical practice. … Gender Disparity in Lung …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

World Conference Conversations: Inside WCLC 2025

Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care

… On Monday, August 8, four researchers will share data showing the benefits of …

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

… of unresectable pleural mesothelioma. 1  However, research published last month in the  Journal of Thoracic … Vincent’s Hospital, Darlinghurst, Australia, and fellow researchers retrospectively collected demographic and … doi:10.1016/S1470-2045(18)30765-4   … PATIENT RESEARCH ADVOCATE ANGUS PRATT REFLECTS ON THE PAST YEAR OF …

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC

… Spigel, MD, Chief Scientific Officer at the Sarah Cannon Research Institute in Nashville, Tennessee, as he began his …